Change in the fatty acid pattern of erythrocyte membrane phospholipids after oral supplementation of specific fatty acids in patients with gastrointestinal diseases

European Journal of Clinical Nutrition

Volumn 64, Issue 4, 2010, Pages 410-418

  Siener, R ^a   Alteheld, B ^a   Terjung, B ^a   Junghans, B ^b   Bitterlich, N ^c   Stehle, P ^a   Metzner, C ^b,d  

^a UNIVERSITY OF BONN   (Germany)

^b Bonn Education Association for Dietetics R A   (Germany)

^c Department of Biostatistics   (Germany)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Fat soluble vitamins; Malabsorption; Maldigestion; N 3 PUFA; Oral supplementation

Indexed keywords

8 ISOPROSTANE; ALPHA TOCOPHEROL; COLECALCIFEROL; DOCOSAHEXAENOIC ACID; GAMMA GLUTAMYLTRANSFERASE; ICOSAPENTAENOIC ACID; LINOLEIC ACID; MEDIUM CHAIN TRIACYLGLYCEROL; MEMBRANE PHOSPHOLIPID; RETINOL; VITAMIN K GROUP; FAT INTAKE; OMEGA 3 FATTY ACID; PHOSPHOLIPID; TRIACYLGLYCEROL; VITAMIN;

ADULT; ALPHA TOCOPHEROL DEFICIENCY; ARTICLE; CELL MEMBRANE FLUIDITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM FUNCTION DISORDER; DOUBLE BLIND PROCEDURE; DOWN REGULATION; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; FATTY ACID ANALYSIS; FEMALE; HUMAN; LIPID COMPOSITION; MALABSORPTION; MALE; OXIDATIVE STRESS; PATIENT COMPLIANCE; PERMEABILITY BARRIER; RANDOMIZED CONTROLLED TRIAL; RETINOL DEFICIENCY; TREATMENT DURATION; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY; ADMINISTRATION AND DOSAGE; AGED; BLOOD; CELL MEMBRANE; CHEMISTRY; DIGESTION; DRUG EFFECTS; ERYTHROCYTE; FAT INTAKE; GASTROINTESTINAL DISEASES; MALABSORPTION SYNDROMES; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; AGED; CELL MEMBRANE; DIETARY FATS; DIETARY SUPPLEMENTS; DIGESTION; DOUBLE-BLIND METHOD; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALABSORPTION SYNDROMES; MALE; MIDDLE AGED; PHOSPHOLIPIDS; TRIGLYCERIDES; VITAMINS;

EID: 77950626737     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2009.151     Document Type: Article

References (46)

1. André P, Balkau B, Born C, Charles MA, Eschwège E, D.E.S.I.R. study group (2006). Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort. Diabetologia 49, 2599-2603.
2. Barceló-Coblijn G, Murphy EJ, Othman R, Moghadasian MH, Kashour T, Friel JK (2008). Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid. Am J Clin Nutr 88, 801-809.
3. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M (1996). Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 334, 1557-1560.
4. Biesalski HK, Böhles H, Esterbauer H, Fürst P, Gey F, Hundsdörfer G et al. (1997). Antioxidant vitamins in prevention. Clin Nutr 16, 151-155.
5. Calder PC (2008). Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 52, 885-897.
6. Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY (2006). Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 52, 2265-2272.
7. Carroccio A, Verghi F, Santini B, Lucidi V, Iacono G, Cavataio F et al. (2001). Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption. Dig Dis Sci 46, 1335-1342.
8. Christophe A, Matthijs F (1967). New method for the determination of the fatty acid pattern of serumlipid classes. Clin Chim Acta 16, 39-43.
9. Das UN (2006). Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J 1, 420-439.
10. DeMeoMT, Mutlu EA, Keshavarzian A, TobinMC (2002). Intestinal permeation and gastrointestinal disease. J ClinGastroenterol 34, 385-396.
11. De Vizia B, Raia V, Spano C, Pavlidis C, Coruzzo A, Alessio M (2003). Effect of an 8-month treatment with o-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. J Parenter Enteral Nutr 27, 52-57.
12. D'Odorico A, Bortolan S, Cardin R, D'Inca R, Martines D, Ferronato A et al. (2001). Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 36, 1289-1294.
13. Ehrhardt J (2002). Labormethoden und Normalwerte für fett- und wasserlösliche Vitamine (Laboratory methods and normal values for fat- and water-soluble vitamins). Vitamine, Spurenelemente und Mineralstoffe. Prävention und Therapie mit Mikronährstoffen (Vitamins, trace elements and minerals. Prevention and therapy with micronutrients), In: (eds). KH Biesalski, J Köhrle, K Schümann, Georg Thieme Verlag: Stuttgart, 676-682.
14. Emdin M, Pompella A, Paolicchi A (2005). Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease. Triggering oxidative stress within the plaque. Circulation 112, 2078-2080.
15. Folch J, Lees M, Stanley GHS (1957). A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226, 497-509.
16. Guebre-Egziabher F, Rabasa-Lhoret R, Bonnet F, Bastard JP, Desage M, Skilton MR et al. (2008). Nutritional intervention to reduce the n-6/ n-3 fatty acid ratio increases adiponectin concentration and fatty acid oxidation in healthy subjects. Eur J Clin Nutr 62, 1287-1293.
17. Harats D, Dabach Y, Hollander G, Ben-Naim M, Schwartz R, Berry EM et al. (1991). Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma lipoproteins. Atherosclerosis 90, 127-139.
18. Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ et al. (2009). Omega-6 fatty acids and risk for cardiovascular disease. A science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 119, 902-907.
19. Higdon JV, Liu J, Du SH, Morrow JD, Ames BN, Wander RC (2000). Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F2-isoprostanes. Am J Clin Nutr 72, 714-722.
20. Hillier K, Jewell R, Dorrell L, Smith CL (1991). Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut 32, 1151-1155.
21. Hull J, Vervaart P, Grimwood K, Phelan P (1997). Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax 52, 557-560. (Pubitemid 27298509)
22. Hussein N, Ah-Sing E, Wilkinson P, Leach C, Griffin BA, Millward DJ (2005). Long-chain conversion of (13C)linoleic acid and a-linolenic acid in response to marked changes in their dietary intake in men. J Lipid Res 46, 269-280.
23. Koutroubakis IE, Malliaraki N, Dimoulios PD, Karmiris K, Castanas E, Kouroumalis EA (2004). Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease. Dig Dis Sci 49, 1433-1437.
24. Kruidenier L, Kuiper I, Lamers CBHW, Verspaget HW (2003). Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 201, 28-36.
25. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS et al. (2007). Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 27, 127-133.
26. Liou YA, King DJ, Zibrik D, Innis SM (2007). Decreasing linoleic acid with constant a-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr 137, 945-952.
27. Ma TY (1997). Intestinal epithelial barrier dysfunction in Crohn's disease. Proc Soc Exp Biol Med 214, 318-327.
28. Mann STW, Stracke H, Lange U, Klör HU, Teichmann J (2003). Vitamin D3 in patients with various grades of chronic pancreatitis, according to morphological and functional criteria of the pancreas. Dig Dis Sci 48, 533-538.
29. Meisinger C, Döring A, Schneider A, Löwel H, for the KORA Study Group (2006). Serum g-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 189, 297-302.
30. Meister D, Ghosh S (2005). Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease. World J Gastroenterol 11, 7466-7472.
31. Mills SC, Windsor AC, Knight SC (2005). The potential interactions between polyunsaturated fatty acids and colonic inflammatory processes. Clin Exp Immunol 142, 216-228.
32. Mori TA (2004). Effect of fish and fish oil-derived omega-3 fatty acids on lipid oxidation. Redox Rep 9, 193-197.
33. Morrow JD, Chen Y, Brame CJ, Yang J, Sanchez SC, Xu J et al. (1999). The isoprostanes: unique prostaglandin-like products of freeradical- initiated lipid peroxidation. Drug Metab Rev 31, 117-139.
34. Nielsen AA, Jörgensen LGM, Nielsen JN, Eivindson M, Grönbaek H, Vind I et al. (2005). Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids. Aliment Pharmacol Ther 22, 1121-1128.
35. Peretti N, Roy CC, Drouin E, Seidman E, Brochu P, Casimir G et al. (2006). Abnormal intracellular lipid processing contributes to fat malabsorption in cystic fibrosis patients. Am J Physiol Gastrointest Liver Physiol 290, G609-G615.
36. Periago JL, Suarez MD, Pita ML (1990). Effect of dietary olive oil, corn oil and medium-chain triglycerides on the lipid composition of rat red blood cell membranes. J Nutr 120, 986-994.
37. Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesäniemi YA (2000). Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med 248, 230-238.
38. Romano C, Cucchiara S, Barabino A, Annese V, Sferlazzas C (2005). Usefulness of o-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study. World J Gastroenterol 11, 7118-7121.
39. Sabanayagam C, Shankar A, Li JL, Pollard C, Ducatman A (2009). Serum gamma-glutamyl transferase level and diabetes mellitus among US adults. Eur J Epidemiol 24, 369-373.
40. Saito M, Kubo K (2003). Relationship between tissue lipid peroxidation and peroxidizability index after a-linolenic, eicosapentaenoic, or docosahexaenoic acid intake in rats. Br J Nutr 89, 19-28.
41. Shankar A, Li J, Klein BEK, Nieto FJ, Klein R (2008). Serum gammaglutamyltransferase level and peripheral arterial disease. Atherosclerosis 199, 102-109. (Pubitemid 351902197)
42. Trebble TM, Arden NK, Wootton SA, Calder PC, Mullee MA, Fine DR et al. (2004). Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease. Am J Clin Nutr 80, 1137-1144.
43. Vuilleumier JP, Keller HE, Gysel D, Hunziker F (1983). Clinical chemical methods for the routine assessment of the vitamin status in human populations. Part I: the fat-soluble vitamins A and E, and beta-carotene. Int J Vitam Nutr Res 53, 265-272.
44. Whitfield JB (2001). Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38, 263-355.
45. Whiting CV, Bland PW, Tarlton JF (2005). Dietary n-3 polyunsaturated fatty acids reduce disease and colonic proinflammatory cytokines in a mousemodel of colitis. Inflamm Bowel Dis 11, 340-349.
46. Zhao S, Jia L, Gao P, Li Q, Lu X, Li J et al. (2008). Study on the effect of eicosapentaenoic acid on phospholipids composition in membrane microdomains of tight junctions of epithelial cells by liquid chromatography/electrospray mass spectrometry. J Pharm Biomed Anal 47, 343-350.